Lymphocytic hypereosinophilic syndrome (Q107461): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Síndrome hipereosinofílica linfocítica é um subtipo da síndrome hipereosinofílica com a presença de uma população de células T monoclonais detectada em conjunto com populações de células T imunofenotipicamente aberrantes. As manifestações são principalmente cutâneas (dermatite eczematosa, nódulos, pápulas, placas, urticária e -ou angioedema com eritrodermia), bem como sintomas gastrointestinais e reumatológicos, tromboembolismo e linfadenopatia. Um subconjunto desenvolve linfoma de células T. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Lymphocytic hypereosinophilic syndrome is a subtype of Hypereosinophilic Syndrome with the presence of a monoclonal T cell population detected in conjunction with immunophenotypically aberrant T cell populations. Manifestations are mostly cutaneous (eczematous dermatitis, nodules, papules, plaques, urticaria and -or angioedema with erythroderma), as well as gastrointestinal, rheumatological symptoms, thromboembolism and lymphadenopathy. A subset develop T cell lymphoma. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/367714724 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_367714724 | |||||||||||||||
| Property / CURIE: CID11:ID_367714724 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_367714724 | |||||||||||||||
| Property / Canary Token: dki-india-ID_367714724 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
16 August 2026
| |||||||||||||||
| Property / Collection date: 16 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 14:27, 17 August 2026
Lymphocytic hypereosinophilic syndrome is a subtype of Hypereosinophilic Syndrome with the presence of a monoclonal T cell population detected in conjunction with immunophenotypically aberrant T cell populations. Manifestations are mostly cutaneous (eczematous dermatitis, nodules, papules, plaques, urticaria and -or angioedema with erythroderma), as well as gastrointestinal, rheumatological symptoms, thromboembolism and lymphadenopathy. A subset develop T cell lymphoma.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_367714724 |
||
| English | Lymphocytic hypereosinophilic syndrome |
Lymphocytic hypereosinophilic syndrome is a subtype of Hypereosinophilic Syndrome with the presence of a monoclonal T cell population detected in conjunction with immunophenotypically aberrant T cell populations. Manifestations are mostly cutaneous (eczematous dermatitis, nodules, papules, plaques, urticaria and -or angioedema with erythroderma), as well as gastrointestinal, rheumatological symptoms, thromboembolism and lymphadenopathy. A subset develop T cell lymphoma. |
Statements
CID11:ID_367714724
0 references
dki-india-ID_367714724
0 references
Concluído
0 references
16 August 2026
0 references
